ABSL Flexi cap mutual fund review: Needs a sharp turnaround; should you stay invested?

ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

BASIC FACTS
DATE OF LAUNCH
27 AUGUST 1998
CATEGORY

EQUITY
TYPE
FLEXI CAP
AUM*
Rs.16,192 Crore
BENCHMARK
NIFTY 500 TOTAL
RETURN INDEX

WHAT IT COSTS
GROWTH OPTION
NAV**
Rs.1,107.57
IDCW
Rs.117.16
MINIMUM INVESTMENT
Rs.100
MINIMUM SIP AMOUNT
Rs.100
EXPENSE RATIO*** (%)
1.77
EXIT LOAD
1% for redemption within 90 days.

*AS ON 31 DECEMBER 2022
**AS ON 1 FEBRUARY 2023
***AS ON 31 DECEMBER 2022

FUND MANAGER
ANIL SHAH
10 YEARS, 3 MONTHS

Recent portfolio changes
New Entrants: LTIMindtree, Schaeffler India, GMM Pfaudler, Gujarat Fluorochemicals.
Complete Exits: Bajaj Auto, Hero Motocorp, MindTree, Tata Motors, Bandhan Bank, Interglobe Aviation.
Increasing allocation: Apollo Hospitals Enterprise, Mahindra & Mahindra, Radico Khaitan, Sun Pharma.

Should you buy?
This multi cap fund tends to maintain a large cap tilt but retains around 25-35% in mid and small caps. It has pared back exposure to the latter in recent years. Its portfolio size has also been cut down and now features larger positions its top bets. The fund manager leans on a top-down approach with a preference for companies in growth sectors. While the fund’s longer term track record in the hands of its long serving fund manager is healthy, its performance has dipped since 2020, when value style gained favour over growth. The fund needs a sharp turnaround to arrest deteriorating risk-return profile.

(Source: Value Research)